Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CAR immune cells: design principles, resistance and the next generation
Louai Labanieh, Crystal L. Mackall
Nature (2023) Vol. 614, Iss. 7949, pp. 635-648
Closed Access | Times Cited: 338

Showing 1-25 of 338 citing articles:

CAR T therapy beyond cancer: the evolution of a living drug
Daniel Baker, Zoltàn Arany, Joseph A. Baur, et al.
Nature (2023) Vol. 619, Iss. 7971, pp. 707-715
Closed Access | Times Cited: 238
From bench to bedside: the history and progress of CAR T cell therapy
Aroshi Mitra, Amrita Barua, Luping Huang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 181
CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn
Steven Μ. Albelda
Nature Reviews Clinical Oncology (2023) Vol. 21, Iss. 1, pp. 47-66
Closed Access | Times Cited: 178
Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity
Leyuan Ma, Alexander Hostetler, Duncan M. Morgan, et al.
Cell (2023) Vol. 186, Iss. 15, pp. 3148-3165.e20
Open Access | Times Cited: 94
Harnessing the potential of hydrogels for advanced therapeutic applications: current achievements and future directions
Peilin Lu, Dongxue Ruan, Meiqi Huang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 83
Chimeric autoantibody receptor T cells deplete NMDA receptor-specific B cells
S. Momsen Reincke, Niels von Wardenburg, Marie A. Homeyer, et al.
Cell (2023) Vol. 186, Iss. 23, pp. 5084-5097.e18
Open Access | Times Cited: 69
CAR-T cell manufacturing: Major process parameters and next-generation strategies
Melanie Ayala Ceja, Mobina Khericha, Caitlin Harris, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 2
Open Access | Times Cited: 66
Glioblastoma Therapy: Past, Present and Future
Elena Obrador, Paz Moreno-Murciano, María Oriol‐Caballo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2529-2529
Open Access | Times Cited: 63
Forks in the road for CAR T and CAR NK cell cancer therapies
Oula K. Dagher, Avery D. Posey
Nature Immunology (2023) Vol. 24, Iss. 12, pp. 1994-2007
Closed Access | Times Cited: 56
Cancer therapy with antibodies
Suman Paul, Maximilian F. Konig, Drew M. Pardoll, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 6, pp. 399-426
Closed Access | Times Cited: 55
Arming CAR-T cells with cytokines and more: Innovations in the fourth-generation CAR-T development
Lin Tang, Sheng Pan, Xuyong Wei, et al.
Molecular Therapy (2023) Vol. 31, Iss. 11, pp. 3146-3162
Open Access | Times Cited: 47
Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment
Roel Polak, Elisa T. Zhang, Calvin J. Kuo
Nature reviews. Cancer (2024) Vol. 24, Iss. 8, pp. 523-539
Closed Access | Times Cited: 47
A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cells
Victor Tieu, Elena Sotillo, Jeremy Bjelajac, et al.
Cell (2024) Vol. 187, Iss. 5, pp. 1278-1295.e20
Closed Access | Times Cited: 41
Engineered CD47 protects T cells for enhanced antitumour immunity
Sean A. Yamada‐Hunter, Johanna Theruvath, Brianna J. McIntosh, et al.
Nature (2024) Vol. 630, Iss. 8016, pp. 457-465
Open Access | Times Cited: 34
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Lei Peng, Giacomo Sferruzza, Luojia Yang, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 10, pp. 1089-1108
Open Access | Times Cited: 31
Antigen Presenting Cell Mimetic Lipid Nanoparticles for Rapid mRNA CAR T Cell Cancer Immunotherapy
Ann E. Metzloff, Marshall S. Padilla, Ningqiang Gong, et al.
Advanced Materials (2024) Vol. 36, Iss. 26
Open Access | Times Cited: 30
Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture method
Yan-Ruide Li, Yang Zhou, Jiaji Yu, et al.
Nature Biotechnology (2024)
Open Access | Times Cited: 22
A new era of cancer immunotherapy: combining revolutionary technologies for enhanced CAR-M therapy
Na Li, Shinan Geng, Zhenzhen Dong, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 20
Programmable synthetic receptors: the next-generation of cell and gene therapies
Fei Teng, Tongtong Cui, Li Zhou, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Engineering allorejection-resistant CAR-NKT cells from hematopoietic stem cells for off-the-shelf cancer immunotherapy
Yan-Ruide Li, Yang Zhou, Jiaji Yu, et al.
Molecular Therapy (2024) Vol. 32, Iss. 6, pp. 1849-1874
Open Access | Times Cited: 18
Emerging roles of CAR-NK cell therapies in tumor immunotherapy: current status and future directions
Yan Zhong, Jingfeng Liu
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 18
Epigenome editing technologies for discovery and medicine
Sean R. McCutcheon, Dahlia Rohm, Nahid Iglesias, et al.
Nature Biotechnology (2024) Vol. 42, Iss. 8, pp. 1199-1217
Closed Access | Times Cited: 18
CAR-T cell therapy targeting surface expression of TYRP1 to treat cutaneous and rare melanoma subtypes
Sameeha Jilani, Justin D. Saco, Edurne Mugarza, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 17
Beyond the blood: expanding CAR T cell therapy to solid tumors
Uğur Uslu, Carl H. June
Nature Biotechnology (2024)
Closed Access | Times Cited: 17
The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy
Dongming Li, Donghui Cao, Yuanlin Sun, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top